Inventor · disambiguated record
Augusto Canavesi
Also filed as: CANAVESI AUGUSTO
4 granted patents·18 pending applications·10 citations·filing 2006–2013
68Inventor score
Files withTEVA PHARMA8TEVA PHARMACEUTICALS USA INC F3GAVENDA ALES2PLUS CHEMICALS SA2CANAVESI AUGUSTO1
Top patents by PatentIndex Score
22 records- 0189US7442806B2Processes for preparing darifenacin hydrobromideTEVA PHARMA·Filed 2006·Granted Oct 28, 2008·5 cites·1 claims
- 0278US8217061B2Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereofGAVENDA ALE HACEK OVER S·Filed 2009·Granted Jul 10, 2012·5 cites·13 claims
- 0368US2009156831A1Processes for preparing darifenacin hydrobromideMERLI VALERIANO·Filed 2009·Application pending·0 cites
- 0467US8618309B2Sunitinib and salts thereof and their polymorphsJEGOROV ALEXANDR·Filed 2009·Granted Dec 31, 2013·0 cites·5 claims
- 0567US2008269505A1Processes for preparing darifenacin hydrobromideTEVA PHARMA·Filed 2008·Application pending·0 cites
- 0667US2008269503A1Processes for preparing darifenacin hydrobromideTEVA PHARMA·Filed 2008·Application pending·0 cites
- 0766US2008269504A1Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereofTEVA PHARMA·Filed 2008·Application pending·0 cites
- 0866US2008214835A1Processes for preparing darifenacin hydrobromideTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 0966US2008221338A1Processes for preparing darifenacin hydrobromideTEVA PHARMACEUTICALS U S A INC·Filed 2008·Application pending·0 cites
- 1064US2008214846A1Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 1162US2008216562A1Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereofTEVA PHARMACEUTICALS USA INC F·Filed 2008·Application pending·0 cites
- 1259US9067915B2Sunitinib and salts thereof and their polymorphsTEVA PHARMA·Filed 2013·Granted Jun 30, 2015·0 cites·5 claims
- 1356US2009247767A1Processes for preparing sunitinib and salts thereofTEVA PHARMA·Filed 2009·Application pending·0 cites
- 1454US2009131665A1Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCIGAVENDA ALES·Filed 2008·Application pending·0 cites
- 1551US2010256392A1Polymorphs of sunitinib base and processes for preparation thereofTEVA PHARMA·Filed 2008·Application pending·0 cites
- 1649US2009253913A1Process for the preparation of sorafenib and salts thereofROSSETTO PIERLUIGI·Filed 2009·Application pending·0 cites
- 1748US2008207904A1Imatinib base, and imatinib mesylate and processes for preparation thereofMACDONALD PETER·Filed 2007·Application pending·0 cites
- 1848US2009124642A1Crystalline forms of Erlotinib HCI and formulations thereofCANAVESI AUGUSTO·Filed 2008·Application pending·0 cites
- 1944US2009012295A1Amorphous Erlotinib, processes for the preparation thereof, and processes to prepare additional forms of ErlotinibGAVENDA ALES·Filed 2008·Application pending·0 cites
- 2043US2010004449A1Crystalline forms of erlotinib base and erlotinib hclPLUS CHEMICALS SA·Filed 2009·Application pending·0 cites
- 2140US2010160646A1Processes for preparing sunitinib and salts thereofTEVA PHARMA·Filed 2010·Application pending·0 cites
- 2221US2011009596A1Process for the preparation of n-protected-decylaminoethanalPLUS CHEMICALS SA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →